Longeveron Inc. (LGVN)
NASDAQ: LGVN
· Real-Time Price · USD
0.79
0.02 (3.24%)
At close: Oct 03, 2025, 3:59 PM
Longeveron Revenue Breakdown
| Period Ending | Mar 31, 2021 |
|---|---|
| AlzheimersAssociationGrantMember Revenue | 170K |
| AlzheimersAssociationGrantMember Revenue Growth | n/a |
| ClinicalTrialRevenueMember Revenue | 165K |
| ClinicalTrialRevenueMember Revenue Growth | n/a |
| MarylandTEDCOGrantMember Revenue | 41K |
| MarylandTEDCOGrantMember Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 2.59M | 2.94M | 2.82M | 3.13M | 2.12M | 2.2M | 3.28M | 3.37M | 3.52M | 2.01M | 1.92M | 2.32M | 2.66M | 2.27M | 2.37M | 3.02M | 3.31M | 2.26M | 760.51K | 746K | 696K | 736K | 738.7K |
| Selling, General, and Administrative Revenue Growth | -11.97% | +4.22% | -9.70% | +47.27% | -3.55% | -32.97% | -2.67% | -4.15% | +74.85% | +4.68% | -17.12% | -12.85% | +17.38% | -4.27% | -21.62% | -8.73% | +46.65% | +196.77% | +1.95% | +7.18% | -5.43% | -0.37% | n/a |
| Research and Development Revenue | 2.95M | 2.52M | 1.99M | 2.21M | 1.72M | 2.22M | 1.92M | 1.84M | 2.29M | 2.78M | 3.26M | 2.96M | 1.72M | 1.43M | 1.73M | 2.05M | 1.96M | 1.35M | 1.15M | 585K | 642K | 289K | 342.57K |
| Research and Development Revenue Growth | +17.46% | +26.45% | -9.84% | +28.11% | -22.40% | +15.57% | +4.18% | -19.41% | -17.73% | -14.80% | +10.24% | +72.09% | +20.53% | -17.66% | -15.38% | +4.49% | +45.19% | +17.22% | +96.87% | -8.88% | +122.15% | -15.64% | n/a |